Clinical and translational outcomes in patients with primary sclerosing cholangitis and inflammatory bowel disease receiving vedolizumab

被引：1
|
作者：
Williamson, K. D. [1 ,2 ]
Slevin, S. [1 ]
Willberg, C. [2 ]
Chapman, R. [1 ]
Klenerman, P. [1 ,2 ]
Keshav, S. [1 ]
机构：
[1] Univ Oxford, Translat Gastroenterol Unit, Oxford, England
[2] Univ Oxford, Peter Medawar Inst Pathogen Res, Oxford, England
来源：
JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(17)31496-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-370
引用
收藏
页码：S544 / S545
页数：2
相关论文
共 50 条
  • [21] Outcomes of oral vancomycin therapy in patients with primary sclerosing cholangitis and inflammatory bowel disease
    Tan, D.
    Demase, K.
    Little, R.
    Ardalan, Z.
    Taylor, K.
    Sparrow, M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 143 - 144
  • [22] Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
    Singh, Akash
    Bernstein, David
    PRACTICAL GASTROENTEROLOGY, 2019, 43 (11) : 18 - 24
  • [23] Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A GETAID Multicentre Cohort Study
    Caron, Benedicte
    Peyrin-Biroulet, Laurent
    Pariente, Benjamin
    Bouhnik, Yoram
    Seksik, Philippe
    Bouguen, Guillaume
    Caillo, Ludovic
    Laharie, David
    Carbonnel, Franck
    Altwegg, Romain
    Reenaers, Catherine
    Serrero, Melanie
    Trang-Poisson, Caroline
    Nancey, Stephane
    Filippi, Jerome
    Abitbol, Vered
    Savoye, Guillaume
    Vuitton, Lucine
    Viennot, Stephanie
    Fumery, Mathurin
    Reymond, Maud
    Bronowicki, Jean-Pierre
    Reimund, Jean-Marie
    Amiot, Aurelien
    JOURNAL OF CROHNS & COLITIS, 2019, 13 (10): : 1239 - 1247
  • [24] Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease
    Christensen, B.
    Micic, D.
    Gibson, P. R.
    Yarur, A.
    Bellaguarda, E.
    Corsello, P.
    Gaetano, J. N.
    Kinnucan, J.
    Rao, V. L.
    Reddy, S.
    Singh, S.
    Pekow, J.
    Rubin, D. T.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (06) : 753 - 762
  • [25] Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis
    Sano, Hitoshi
    Nakazawa, Takahiro
    Ando, Tomoaki
    Hayashi, Kazuki
    Naitoh, Itaru
    Okumura, Fumihiro
    Miyabe, Katsuyuki
    Yoshida, Michihiro
    Takahashi, Satoru
    Ohara, Hirotaka
    Joh, Takashi
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2011, 18 (02) : 154 - 161
  • [26] All That Glitters is Not Gold in Vedolizumab Therapy for Patients With Inflammatory Bowel Diseases and Primary Sclerosing Cholangitis
    Roda, Giulia
    Lleo, Ana
    Danese, Silvio
    Aghemo, Alessio
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (01) : 51 - 53
  • [27] Associations Between Drug Exposure and Outcomes in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
    Fung, Brian M.
    Ali, Ahmad H.
    Tabibian, James H.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (05) : 1244 - 1245
  • [28] Predicting outcomes of disease in patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: a retrospective multicentric study
    Oliveira, R.
    Viegas, M., I
    Abrantes, D.
    Conde, P. Vaz
    Saraiva, M.
    Espinheira, M. D. C.
    Trindade, E.
    Carvalho, I
    Perdigoto, D.
    de Sousa, H. Tavares
    Roseira, J.
    GED, II
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i915 - i915
  • [29] Prevalence and phenotype of inflammatory bowel disease in patients with primary sclerosing cholangitis
    Huynh, D.
    Bate, J. P.
    Andrews, J. M.
    Johnson, D.
    Nind, G.
    Harley, Haj
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 48 - 48
  • [30] Endoscopic features of inflammatory bowel disease in patients with primary sclerosing cholangitis
    Smith, Timothy
    Swaroop, Prabhakar
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S454 - S454
12345